Weyer Andy D, Lehto Sonya G
Pacific University School of Physical Therapy, Hillsboro, OR 97123, USA.
One Amgen Center Dr, Thousand Oaks, CA 91320, USA.
Pharmaceuticals (Basel). 2017 Mar 30;10(2):37. doi: 10.3390/ph10020037.
A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.
综述。为治疗慢性疼痛和偏头痛,人们一直在研发瞬时受体电位 melastatin 8(TRPM8)的药物拮抗剂。本综述聚焦于这一进展的当前状况。